Posters
2023
2022
Validation of a New Kit for the Determination of Factor IX Activity
Hypercoagulability in COVID-19: Is there an Antiphospholipid Syndrome?
2021
Impact of Inactive FVIII Antigen in FVIII Deficient Plasma on the Measurement of FVIII Inhibitors
Validation of a New Kit for the Quantitative Determination of Chromogenic FIX Activity
Laboratory Validation of CRYOcheck™ Chromogenic Factor VIII Across Multiple Coagulation Analyzers
2020
Comparison of Hexagonal Phase Phospholipid Neutralization Assays for Lupus Anticoagulant Detection
CRYOcheck™ Chromogenic Factor VIII: A New Kit for the Determination of FVIII:C Activity
2019
Effects of Common Interferents in Hexagonal Phase Phospholipid Neutralization Testing
2018 and Earlier
Assessment of clotting activity of recombinant FIX Fc fusion protein in European HTCs
(Poster available to healthcare professionals only; login required)
Articles
Pipe S, Sadeghi-Khomami A, Konkle BA, et al. A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one-stage clotting and chromogenic substrate assays at clinical haemostasis laboratories. Haemophilia. 2023;1-10.
Sommer JM, Sadeghi-Khomami A, Barnowski C, Wikén M, Willemze AJ. Real-world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples. Int J Lab Hematol. 2020;42:350–358.